Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company H3 Biomedicine Inc.
DescriptionSmall molecule modulator of splicing factor 3B subunit 1 (SF3B1)
Molecular Target Splicing factor 3B subunit 1 (SF3B1)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationHematologic malignancies
Indication DetailsTreat hematologic malignancies
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today